Mindfulness meditation for pulmonary hypertension program development: Acceptability and feasibility of technology-assisted complementary health intervention for symptom self-management.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Mindfulness meditation for pulmonary hypertension program development: Acceptability and feasibility of technology-assisted complementary health intervention for symptom self-management.
Συγγραφείς: Von Visger TT; Assistant Professor, The Medical University of South Carolina, College of Nursing, Charleston, SC, USA. Electronic address: vonvisge@musc.edu., Chang YP; Associate Dean for Research and Scholarship, Associate Professor, School of Nursing, The State University of New York, University at Buffalo, Buffalo, NY, USA.
Πηγή: Heart & lung : the journal of critical care [Heart Lung] 2026 Jul-Aug; Vol. 78, pp. 102759. Date of Electronic Publication: 2026 Mar 12.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Mosby Country of Publication: United States NLM ID: 0330057 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3288 (Electronic) Linking ISSN: 01479563 NLM ISO Abbreviation: Heart Lung Subsets: MEDLINE
Imprint Name(s): Original Publication: St. Louis, Mosby.
Ιατρικοί όροι (MeSH): Hypertension, Pulmonary*/therapy , Hypertension, Pulmonary*/psychology , Mindfulness*/methods , Meditation*/methods , Self-Management*/methods , Quality of Life* , Program Development*, Humans ; Female ; Male ; Middle Aged ; Feasibility Studies ; Adult ; Aged ; Patient Acceptance of Health Care ; Mobile Applications ; Pilot Projects ; Digital Health
Περίληψη: Background: Adults with pulmonary hypertension (PH) live with a high symptom burden, psychological distress, and poor quality of life. Mindfulness-based interventions delivered in person or virtually have shown clinical benefits for chronic conditions and PH. Pilot testing of the Mindfulness Meditation for Pulmonary Hypertension (MMPH), an 8-week, web-based, multimodal program, shows improvement in depression, symptoms, and quality of life.
Objectives: To evaluate the MMPH program's acceptability and feasibility quantitatively and qualitatively from MMPH participants.
Methods: Descriptive statistics were used to report adherence to and completion of each component of MMPH (Zoom, video, and app use) among 15 participants who received the intervention in 2022-2023. Qualitative thematic analysis was conducted on their daily reflection journals, downloaded from the MMPH app.
Results: Fifteen participants attended 28 out of 30 Zoom sessions (93%). Twelve of 15 (80%) participants accessed the video-viewing activity at least 50% of the time (3 of 6 videos). Eight out of 15 participants (53%) used the App during the intervention period, and 6 out of 15 participants (40%) used the App for >2 weeks. The content analysis reveals four most salient themes: Perceived Benefits of Meditation, Daily Life Practice and Activity, Awareness and Acceptance, and PH Symptom Improvement. The System Usability Scale for the MMPH program was 81.47 (±10.21), indicating moderate acceptability.
Conclusions: Assessing the feasibility and acceptability of a complex behavioral health intervention, such as the MMPH program, is critical to ensuring consistent intervention fidelity. Comprehensive approaches are essential to guide necessary program modifications for future real-world implementation science testing.
(Copyright © 2026 The Authors. Published by Elsevier Inc. All rights reserved.)
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Grant Information: UL1 TR001412 United States TR NCATS NIH HHS
Contributed Indexing: Keywords: Acceptability; Complementary health approach (CHA); Feasibility; Intervention fidelity monitoring (IFM); Meditation; Mindfulness; Mindfulness mobile app; Pulmonary hypertension (PH)
Entry Date(s): Date Created: 20260313 Date Completed: 20260617 Latest Revision: 20260726
Update Code: 20260726
PubMed Central ID: PMC13340582
DOI: 10.1016/j.hrtlng.2026.102759
PMID: 41825305
Βάση Δεδομένων: MEDLINE